Download PDF
Thromb Haemost 1993; 70(01): 068-071
DOI: 10.1055/s-0038-1646162
State-of-the-Art Lecture
Factor XI
Schattauer GmbH Stuttgart

Factor XI Deficiency

Uri Seligsohn
Department of Hematology, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Tel-Aviv University, ISRAEL
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry 1987; 26: 7221-8
    CrossrefPubMedGoogle Scholar
  • 2 Kato A, Asakai R, Davie EW, Aoki N. Factor XI gene (Fll) is located on the distal end of the long arm of human chromosome 4. Cyto-genet Cell Genet 1989; 52: 77-8
    CrossrefPubMedGoogle Scholar
  • 3 Rapaport SI, Proctor RR, Patch MJ, Yettra M. The mode of inheritance of PTA deficiency: Evidence for the existence of major PTA deficiency and minor PTA deficiency. Blood 1961; 18: 149-65
    CrossrefPubMedGoogle Scholar
  • 4 Leiba H, Ramot B, Many R. Heredity and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 1965; 11: 654-65
    CrossrefPubMedGoogle Scholar
  • 5 Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood 1978; 51: 1223-8
    PubMedGoogle Scholar
  • 6 Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PW. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 1985; 65: 719-24
    PubMedGoogle Scholar
  • 7 Bolton-Maggs PHB, Young-Wan-Yin R, McCraw A, Slack J, Ker-noff PBA. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69: 521-8
    CrossrefPubMedGoogle Scholar
  • 8 Saito H, Ratnoff OD, Bouma BN, Seligsohn U. Failure to detect variant (CRM+) plasma thromboplastin antecedent (PTA, factor XI) molecules in hereditary PTA deficiency: A study of 125 patients of several ethnic backgrounds. J Lab Clin Med 1985; 106: 718-22
    PubMedGoogle Scholar
  • 9 Mannhalter C, Hellstern P, Deutsch E. Identification of a defective factor XI cross-reacting material in a factor XI deficient patient. Blood 1987; 70: 31-7
    PubMedGoogle Scholar
  • 10 Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 1989; 86: 7667-71
    CrossrefPubMedGoogle Scholar
  • 11 Meijers JCM, Davie EW, Chung DW. Expression of human blood coagulation factor XI: Characterization of the defect in factor XI type III deficiency. Blood 1992; 79: 1435-40
    PubMedGoogle Scholar
  • 12 Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325: 153-8
    CrossrefPubMedGoogle Scholar
  • 13 Bolton-Maggs PHB, Lloyd J, Wensley RT, Tuddenham EGD. Genetic analysis of 27 kindreds with factor XI deficiency from North West England. Abstracts 24th Congress. International Society of Haematology; London: 1992: 511a
    Google Scholar
  • 14 Biggs R, Sharp AA, Margolis J, Hardisty RM, Stewart J, Davidson WM. Defects in the early stages of blood coagulation: A report of four cases. Br J Haematol 1958; 4: 177-92
    CrossrefPubMedGoogle Scholar
  • 15 Seligsohn U, Weiss E, Kulka T, Eichel R, Zwang E, Peretz H. The frequency of Type II and Type III mutations causing Factor XI deficiency in the general Jewish population. Thromb Haemostas. 1993 69. (in press), (abstr.)
    PubMedGoogle Scholar
  • 16 Hancock JF, Wieland K, Pugh RE, Martinowitz U, Schulman S, Kakkar VV, Kernoff PBA, Cooper DN. A molecular genetic study of factor XI deficiency. Blood 1991; 77: 1942-8
    PubMedGoogle Scholar
  • 17 Seligsohn U, Peretz H, Spielberg O, Eichel R, Asakai R, Davie EW. A nonsense (Type II)) mutation accounts for Factor XI deficiency in 4 unrelated Iraqi-Jewish families. Thromb Haemostas 1991; 65: 808a
    PubMedGoogle Scholar
  • 18 Lipscomb MS, Walsh RN. Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI. J Clin Invest 1979; 63: 1006-14
    CrossrefPubMedGoogle Scholar
  • 19 Sidi A, Seligsohn U, Jonas P, Many M. Factor XI deficiency: detection and management during urologic surgery. J Urol 1978; 119: 528-30
    CrossrefPubMedGoogle Scholar
  • 20 Bolton-Maggs PHB, Hay CRM, Tuddenham EGD, Wensley RT. Definition of the bleeding tendency in factor XI-deficient kindreds. Abstract 24th Congress. International Society of Haematology; London: 1992: 201a
    Google Scholar
  • 21 Kitchens CS. Factor XI: A review of its biochemistry and deficiency. Semin Thromb Hemostas 1991; 17: 55-72
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Seligsohn U, Modan M. Definition of the population at risk of bleeding due to factor XI deficiency in Ashkenazi Jews and the value of the activated partial thromboplastin time in its detection. Israel J Med Sci 1981; 17: 413-15
    PubMedGoogle Scholar
  • 23 Bolton-Maggs PHB, Wensley RT, Kernoff PBA, Kasper CK, Winkelman L, Lane RS, Smith JK. Production and therapeutic use of a factor XI concentrate from plasma. Thromb Haemostas 1992; 67: 314-9
    PubMedGoogle Scholar
  • 24 Burnouf-Radosevich M, Burnouf T. A therapeutic, highly purified factor XI concentrate from human plasma. Transfusion 1992; 32: 861-7
    CrossrefPubMedGoogle Scholar
  • 25 Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U. Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinol 1992; 3: 465-8
    CrossrefPubMedGoogle Scholar